These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2495909)

  • 1. Comparison of tissue plasminogen activator and streptokinase in the management of acute myocardial infarction.
    White HD
    Chest; 1989 May; 95(5 Suppl):265S-269S. PubMed ID: 2495909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombolysis, streptokinase, and TPA in the treatment of acute myocardial infarction.
    Mock MB; Chesebro JH
    Cardiovasc Clin; 1987; 18(1):247-57. PubMed ID: 2955892
    [No Abstract]   [Full Text] [Related]  

  • 4. Acylated plasminogen-streptokinase activator complex: a new approach to thrombolytic therapy.
    Crabbe SJ; Grimm AM; Hopkins LE
    Pharmacotherapy; 1990; 10(2):115-26. PubMed ID: 2140889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of clinical efficacy of thrombolytic drugs in patients with acute myocardial infarction].
    López-Sendón JL
    Rev Esp Cardiol; 1992; 45 Suppl 2():9-20. PubMed ID: 1475514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombolytic therapy for MI.
    Rodriguez SW; Reed RL
    Am J Nurs; 1987 May; 87(5):631-40. PubMed ID: 3107386
    [No Abstract]   [Full Text] [Related]  

  • 7. Thrombolysis for acute myocardial infarction: drug review.
    Cundiff DK
    MedGenMed; 2002 Jan; 4(1):1. PubMed ID: 11965203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of tissue plasminogen activator and streptokinase on infarct size and on rate of enzyme release: influence of early infarct related artery patency. The GUSTO Enzyme Substudy.
    Baardman T; Hermens WT; Lenderink T; Molhoek GP; Grollier G; Pfisterer M; Simoons ML
    Eur Heart J; 1996 Feb; 17(2):237-46. PubMed ID: 8732377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative assessment of efficacy of tissue plasminogen activator and streptokinase in the treatment of patients with acute myocardial infarction].
    Shul'man VA; Radionov VV; Golovenkin SE; Pediashov VE; Linev KA; Titarenko OM; Simulin VN; Pasal'skiĭ VL; Peterson LS; Necheporenko GI; Kononova LI; Peterson EV
    Kardiologiia; 2004; 44(5):40-2. PubMed ID: 15159721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stroke complicating acute myocardial infarction. A meta-analysis of risk modification by anticoagulation and thrombolytic therapy.
    Vaitkus PT; Berlin JA; Schwartz JS; Barnathan ES
    Arch Intern Med; 1992 Oct; 152(10):2020-4. PubMed ID: 1417374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safe use of thrombolysis in the elderly.
    Wittry MD; Thornton TA; Chaitman BR
    Geriatrics; 1989 Nov; 44(11):28-30, 33-6. PubMed ID: 2509296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thrombolysis in acute myocardial infarction. Streptokinase or r-TPA?].
    Silva LA; Ribeiro E; Carneiro RC; Kaissar S; Reis Filho A; Torossian SP; Tavares JR; Buffolo E; Amino JG; Duprat Filho R
    Arq Bras Cardiol; 1990 Jul; 55(1):13-7. PubMed ID: 2127353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The thrombolysis in myocardial infarction (TIMI) trial phase I and phase IIA pilot results. Implications for nursing.
    Brewer-Senerchia C
    Prog Cardiovasc Nurs; 1988; 3(4):128-36. PubMed ID: 2974593
    [No Abstract]   [Full Text] [Related]  

  • 14. Thrombolytic therapy for acute myocardial infarction.
    Bates ER; Topol EJ
    Chest; 1989 May; 95(5 Suppl):257S-264S. PubMed ID: 2523296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant tissue-type plasminogen activator as a thrombolytic agent in acute myocardial infarction.
    Parr KL; Valentine RP; Pitts DE; Schumacher RR; Schmidt PE; Brooks-Brunn JA; Ramsden C
    Indiana Med; 1987 May; 80(5):460-1. PubMed ID: 2953781
    [No Abstract]   [Full Text] [Related]  

  • 16. Guidelines for the use of intravenous thrombolytic agents in acute myocardial infarction. Ontario Medical Association Consensus Group on Thrombolytic Therapy.
    Naylor CD; Armstrong PW
    CMAJ; 1989 Jun; 140(11):1289-99. PubMed ID: 2497946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular function as an end-point of thrombolytic therapy.
    Norris RM; White HD
    Eur Heart J; 1990 Aug; 11 Suppl F():5-9. PubMed ID: 2121490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombolytic therapy in Europe: current status.
    Vahanian A
    Eur Heart J; 1996 Sep; 17 Suppl E():21-7. PubMed ID: 11824000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient reperfusion preferences in acute myocardial infarction: mortality versus stroke, benefits versus costs, high technology versus drugs.
    Tsui W; Pierre K; Massel D
    Can J Cardiol; 2005 Apr; 21(5):423-31. PubMed ID: 15861260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombolysis in acute myocardial infarction: analysis of studies comparing accelerated t-PA and streptokinase.
    Smith BJ
    J Accid Emerg Med; 1999 Nov; 16(6):407-11. PubMed ID: 10572811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.